Hims Hers Health is trading 4.01% down at $30.38 after no clear company-specific catalyst was identified for the August 6, 2026 decline.
- The company announced a new AI-native Hers care experience for weight-loss members, but it does not explain the selloff.
- Shares are retreating after a sharp recent rally, while healthcare is higher overall.
- The recent FTC lawsuit remains a regulatory overhang.